Company Autobio Diagnostics Co., Ltd.

Equities

603658

CNE100002GC4

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Autobio Diagnostics Co., Ltd.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Diagnostic & Testing Substances

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
57.57 ^CNY	+2.38%		+9.55%	+0.98%

Apr. 19	Autobio Diagnostics' Q1 Profit Jumps 34%	MT
Apr. 19	Autobio Diagnostics' 2023 Profit Climbs 4% as Operating Income Stays Flat	MT

Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.

Number of employees: 5,539

CNY in Million	2022	Weight	2023	Weight	Delta
Reagent 85.9 %	3,530	79.5 %	3,815	85.9 %	+8.06%
Instrument 10.9 %	720	16.2 %	482	10.9 %	-32.99%
Others 2.1 %	138	3.1 %	95	2.1 %	-31.46%
Maintenance 1.2 %	53	1.2 %	52	1.2 %	-2.81%

CNY in Million	2022	Weight	2023	Weight	Delta
China 95.3 %	4,236	97.0 %	4,234	95.3 %	-0.03%
Overseas 4.7 %	130	3.0 %	209	4.7 %	+60.93%

Managers	Title	Age	Since
Zeng Li Yang CEO	Chief Executive Officer	56	02-12-31
Chao Jie Feng DFI	Director of Finance/CFO	46	02-12-31
Yong Jun Miao CHM	Chairman	57	02-12-31
Wei Liu ADM	Chief Administrative Officer	48	05-12-31
Guang Yu Fu BRD	Director/Board Member	55	02-12-31
Xue Wei Wu BRD	Director/Board Member	57	02-12-31
Na Wang IRC	Investor Relations Contact	38	18-10-28
Rui Kuan Fang IRO	Public Communications Contact	53	02-12-31

Members of the board	Title	Age	Since
Yong Jun Miao CHM	Chairman	57	02-12-31
Ya Xun Zhang BRD	Director/Board Member	59	05-12-31
Xue Wei Wu BRD	Director/Board Member	57	02-12-31
Zeng Li Yang CEO	Chief Executive Officer	56	02-12-31
Guang Yu Fu BRD	Director/Board Member	55	02-12-31
Chao Jie Feng DFI	Director of Finance/CFO	46	02-12-31
Ming Ming Han CHM	Chairman	54	02-12-31
Zhong Ming Ye BRD	Director/Board Member	56	18-10-28
Zhi Jun Li BRD	Director/Board Member	62	18-10-28
Ding Wang BRD	Director/Board Member	47	18-10-28

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	591,533,166	183,185,067 ( 30.97 %)	5,260,910 ( 0.8894 %)	30.97 %

Name	Equities	%	Valuation
Zhengzhou Antu Industrial Group Co., Ltd. 55.23 %	323,804,473	55.23 %	2 551 M ¥
Zhang Family 13.12 %	76,892,416	13.12 %	606 M ¥
Zhong Geng Fund Management Co. , Ltd. 3.203 %	18,778,020	3.203 %	148 M ¥
Aegon-Industrial Fund Management Co., Ltd. 1.312 %	7,694,221	1.312 %	61 M ¥
Hwabao WP Fund Management Co., Ltd. 1.048 %	6,142,425	1.048 %	48 M ¥
AUTOBIO DIAGNOSTICS CO., LTD. 0.8973 %	5,260,910	0.8973 %	41 M ¥
UBS AG (Investment Management) 0.7021 %	4,116,246	0.7021 %	32 M ¥
Shanghai Minghe Investment Management Co. Ltd. 0.6140 %	3,600,000	0.6140 %	28 M ¥
Hua Life Insurance Co., Ltd. 0.5445 %	3,192,090	0.5445 %	25 M ¥
UBS SDIC Fund Management Co., Ltd. 0.4409 %	2,585,138	0.4409 %	20 M ¥

Name	Equities	%	Valuation
AUTOBIO DIAGNOSTICS CO., LTD. 0.90%	5,260,910	0.90%	41,447,027 $

Autobio Diagnostics Co., Ltd.

No. 199 Jingkai 15th Street Economic & Technological Dev Zone

450016, Zhengzhou

http://www.autobio.com.cn

address Autobio Diagnostics Co., Ltd.(603658)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

57.57 CNY

Average target price

64.39 CNY

Spread / Average Target

+11.84%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
AUTOBIO DIAGNOSTICS CO., LTD.	+0.98%	4.61B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-11.57%	7.5B
DIASORIN S.P.A.	+2.98%	5.48B
LANTHEUS HOLDINGS, INC.	+5.18%	4.47B
10X GENOMICS, INC.	-50.82%	3.28B
ANDON HEALTH CO., LTD.	+11.23%	2.71B
VITROLIFE AB	-16.38%	2.02B
MYRIAD GENETICS, INC.	-2.66%	1.69B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-10.84%	1.74B
SANSURE BIOTECH INC.	-4.35%	1.48B

Diagnostic & Testing Substances